Predictions
Sage Therapeutics Inc.
Start price
Target price
Perf. (%)
€37.80
04.04.23
04.04.23
-
04.04.24
04.04.24
-37.04%
31.01.24
31.01.24
Uniqure B.V.
Start price
Target price
Perf. (%)
€5.79
07.01.24
07.01.24
-
07.01.25
07.01.25
-10.88%
20.01.24
20.01.24
Could be worthwhile Investment >10% per year
Hutchison China MediTech Ltd ADR
Start price
Target price
Perf. (%)
€15.50
19.01.23
19.01.23
-
19.01.24
19.01.24
-21.29%
20.01.24
20.01.24
Bluebird Bio Inc.
Start price
Target price
Perf. (%)
€4.00
02.12.23
02.12.23
€5.00
31.10.25
31.10.25
-30.50%
10.12.23
10.12.23
Could be very worthwhile Investment >20% year
MorphoSys AG
Start price
Target price
Perf. (%)
€17.06
26.11.23
26.11.23
-
26.11.24
26.11.24
57.74%
09.12.23
09.12.23
Could be worthwhile Investment >10% per year
MorphoSys AG
Start price
Target price
Perf. (%)
€17.06
26.11.23
26.11.23
-
26.11.24
26.11.24
57.74%
09.12.23
09.12.23
Could be worthwhile Investment >10% per year
Arrowhead Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€19.62
30.11.23
30.11.23
-
30.11.24
30.11.24
12.62%
08.12.23
08.12.23
Could be very worthwhile Investment >20% year
Canopy Growth Corp
Start price
Target price
Perf. (%)
€3.58
21.11.22
21.11.22
-
21.11.23
21.11.23
-85.09%
22.11.23
22.11.23
Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
Innovative
Future proof or reliable business model
PTC Therapeutics Inc.
Start price
Target price
Perf. (%)
€17.20
28.10.23
28.10.23
€8.00
28.10.24
28.10.24
-4.07%
11.11.23
11.11.23
Probably not worthwhile Investment
Revenue decline/stagnation expected
Lower EBIT Margin than peer group
negative Cash Flow expected
Medpace Holdings Inc
Start price
Target price
Perf. (%)
€218.90
25.10.22
25.10.22
€190.00
25.10.23
25.10.23
11.47%
26.10.23
26.10.23
Could be worthwhile Investment >10% per year
Mirati Therapeutics Inc.
Start price
Target price
Perf. (%)
€59.10
05.10.23
05.10.23
-
05.10.24
05.10.24
-8.93%
15.10.23
15.10.23
Could be worthwhile Investment >10% per year
Acadia Pharmaceuticals
Start price
Target price
Perf. (%)
€19.60
30.09.23
30.09.23
€9.00
30.09.24
30.09.24
11.22%
14.10.23
14.10.23
Probably not worthwhile Investment
Revenue decline/stagnation expected
EBIT decline/stagnation expected
Lower EBIT Margin than peer group